Johnson & Johnson JNJ

$275.20 +4.16 (1.53%)

Valuation

Market cap
652,477,312,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
25.23
Forward PE
24.17
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
6,023,500
Avg volume
6,922,038
Day's range
$273.60 – $278.05
Shares out
2,407,310,000
Stochastic %K
89%
Beta
0.21
Analysts
Strong Sell
Price target
$281.88

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Baddb Oct 30, 2:28 PM
$JNJ 👀😂😈
0 replies
Baozun13 Oct 30, 12:41 PM
$JNJ why did this suddenly double is there any fundamental change or is this just a sign of the times -
1 replies
gayforsanjay Oct 30, 12:13 PM
Next up go experience reality is $WMT $COST $PEP $JNJ $PG
1 replies
gayforsanjay Oct 30, 11:42 AM
$COST $WMT $JNJ $PEP enjoy your short term fun. We know what happens next. Stocks don’t just go up because other stocks come down. There has to be a fundamental reason. I don’t see any.
1 replies
viggizags Oct 30, 9:53 AM
$SPY i mean not for nothing look at Woody Johnson coin $JNJ and compare that to the index or tech. Dont have a position but it illustrates my point.
0 replies
gogogomm Oct 30, 9:23 AM
$JNJ $NRXP NRXP Ketaminfree has received FDA approval. below https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=220602 moon!!!
2 replies
juice_rock Oct 30, 7:38 AM
$JNJ will go up at least through the election as a safe haven from election uncertainty. likely rotation from tech sector if democrats take the house due to perceived hostility to data center buildout. republicans retaining power is short term broad-sector bearish due to threats of new iran war, bullish for defense, possible minor bullish for safe haven stocks. democrats taking power is short term bullish if it prevents a new iran war + depending how much democrats gain potential long term bullish if it means increased healthcare spending.
0 replies
TheStockTraderHub Oct 30, 3:20 AM
$JNJ daily calling for all time highs retest 👀
0 replies